Zimmer Biomet Hit With Chancery Suit Over $2B PE Cashout
Medical device manufacturer Zimmer Biomet has been hit with a derivative suit in Delaware Chancery Court alleging company officers hid compliance problems at a factory that led to a stock drop...To view the full article, register now.
Already a subscriber? Click here to view full article